MINERVAX ApS: Financial statements 2014
CVR: 32673287
Source: annual report 2014, Danish Business Authority
01/01/2014 – 31/12/2014
MINERVAX ApS (CVR 32673287) has filed annual accounts for 2014. In 2014, the company reported a gross profit of DKK -5,356,678 and a net result of DKK -4,412,692 compared with DKK -2,146,519 the year before. Equity in the 2014 report amounted to DKK 13,515,506. The solvency ratio was 74.7%.
- Gross Profit
- DKK -5,356,678
- Profit/Loss
- DKK -4,412,692
- Equity
- DKK 13,515,506
- Total Assets
- DKK 18,092,802
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2014 | - | -5.4 mio. | -4.4 mio. | 13.5 mio. | - |
| 2013 | 4.6 mio. | -2.6 mio. | -2.1 mio. | -719 t. | - |
| 2012 | - | -1.1 mio. | -846 t. | 1.4 mio. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2014
As of May 30, 2014, Carsten Schou has joined the board of directors of MINERVAX ApS.
As of May 30, 2014, Line Holten Reimer has left the board of directors of MINERVAX ApS.
MINERVAX ApS has published its annual report for 2013. Revenue came to DKK 4,568,982, and the net result was DKK -2,146,519.
As of January 2, 2014, Sten Verland has joined the board of directors of MINERVAX ApS.
As of January 2, 2014, Nanna Liebach Lüneborg has joined the board of directors of MINERVAX ApS.
As of January 2, 2014, Carl Fredrik Siwmark has joined the board of directors of MINERVAX ApS.
As of January 2, 2014, Carl Gunnar Lindahl has left the board of directors of MINERVAX ApS.
About MINERVAX ApS
MINERVAX ApS is a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2010. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Per Bo Pedersen Fischer. The board consists of Veronica Gambillara Fonck (chair), Bita Sehat, Christopher J. Gagliardi and Emmanuelle Coutanceau. The company's owners include Novo Holdings A/S, SUNSTONE LIFE SCIENCE VENTURES FUND III K/S and Wellington Partners Life Sciences V GmbH & Co. KG. The company has 2 employees (2018). In 2025, the company reported a net result of EUR -31,530,000 compared with EUR -29,126,000 the year before. Equity in the 2025 report amounted to EUR 9,787,000.